Since 2013, we have sold 45,000 cupcakes and raised nearly a million dollars through Cal's Cupcake Challenge, The Cupcake Gala, the Cupcake Run, and with gifts from donors and partners. Our mission is to improve care, support families and champion research for families with Leukodystrophy.
The revolutionary and life-saving MLD gene therapy treatment, OTL-200, is scheduled for review by the FDA in March 2024, meaning that it soon could be available to MLD patients in the United States. With the potential FDA approval of OTL-200, the MLD community has hope for a brighter future where those affected by the rare disease get a second chance at life.
Join us in making a difference for MLD patients and their families across the country as we work to ensure that they can access this incredible treatment. Your support can make an impact by helping make this life-saving treatment accessible to those in need.
We strive to provide improved care for families dealing with MLD and Leukodystrophy. Our dedicated team of professionals is committed to offering support and resources to enhance the quality of life for patients and their loved ones.
At The Calliope Joy Foundation, we are dedicated to funding research initiatives that aim to find a cure for MLD and Leukodystrophy. By supporting groundbreaking research, we hope to bring hope and progress to those affected by these conditions.